Transaction in Own Shares

Summary by AI BETAClose X

CVS Group plc has purchased 24,653 of its ordinary shares on December 3, 2025, as part of its ongoing share buyback program, with prices ranging from 1,200.00 pence to 1,232.00 pence per share, averaging 1,215.11 pence. These shares will be cancelled, reducing the total number of issued ordinary shares to 70,995,821, with no shares held in treasury. Since the program's inception, CVS has repurchased a total of 744,962 ordinary shares at a weighted average price of 1,215.97 pence.

Disclaimer*

CVS Group plc
04 December 2025
 

04 December 2025

 

CVS GROUP plc

("CVS" or the "Company" and, together with its subsidiaries, the "Group")

Transaction in own shares

 

CVS announces that on 03 December 2025 it purchased the following number of its ordinary shares of 0.2 pence each ("Ordinary Shares") from Joh. Berenberg, Gossler & Co. KG, London Branch ("Berenberg"), in accordance with the terms of the share buyback programme announced on 24 October 2025 (the "Share Buyback Programme").

 

Date of purchase:

03/12/2025

Aggregate number of Ordinary Shares purchased:

24,653

Lowest price paid per share (GBp):

1,200.00

Highest price paid per share (GBp):

1,232.00

Volume weighted average price paid per share (GBp):

1,215.11


CVS intends to cancel all of the purchased Ordinary Shares.

 

Following settlement of the above purchases and cancellation of the Ordinary Shares purchased, CVS will have 70,995,821 Ordinary Shares in issue and holds no Ordinary Shares in treasury.

 

The total number of voting rights in CVS is therefore 70,995,821 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, CVS under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

Since the commencement of the Share Buyback Programme, the Company has repurchased 744,962 Ordinary Shares in aggregate at a weighted average price of 1,215.97 pence per share.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), as it forms part of Retained EU Law as defined in the European Union (Withdrawal) Act 2018, the table below contains detailed information of the individual trades made by Berenberg as part of the Share Buyback Programme.

 

Individual transactions:

 

Number of

Ordinary Shares purchased

Transaction price (GBp share)

Time of

transaction (UK Time)

Transaction

reference number

Trading Venue

 


301

1232

03/12/2025 08:17:01

1344660387665002

XLON


98

1230

03/12/2025 08:17:16

1344660387665023

XLON


200

1226

03/12/2025 08:23:09

1344660387665656

XLON


600

1226

03/12/2025 08:23:57

1344660387665713

XLON


7

1226

03/12/2025 08:23:57

1344660387665714

XLON


7

1226

03/12/2025 08:23:57

1344660387665715

XLON


309

1224

03/12/2025 08:26:49

1344660387666086

XLON


91

1224

03/12/2025 08:26:49

1344660387666088

XLON


518

1220

03/12/2025 08:52:16

1344660387669367

XLON


71

1218

03/12/2025 08:52:18

1344660387669373

XLON


336

1222

03/12/2025 09:27:20

1344660387672055

XLON


538

1220

03/12/2025 09:44:19

1344660387673819

XLON


161

1218

03/12/2025 09:44:19

1344660387673822

XLON


155

1216

03/12/2025 09:44:25

1344660387673860

XLON


155

1214

03/12/2025 09:44:35

1344660387673876

XLON


14

1204

03/12/2025 09:57:10

1344660387674949

XLON


57

1204

03/12/2025 09:57:10

1344660387674950

XLON


98

1202

03/12/2025 09:57:36

1344660387675022

XLON


333

1200

03/12/2025 09:58:21

1344660387675072

XLON


66

1200

03/12/2025 09:59:44

1344660387675195

XLON


171

1200

03/12/2025 09:59:44

1344660387675196

XLON


540

1206

03/12/2025 10:16:47

1344660387676496

XLON


320

1206

03/12/2025 10:16:47

1344660387676500

XLON


16

1206

03/12/2025 10:16:47

1344660387676501

XLON


88

1208

03/12/2025 10:30:10

1344660387677723

XLON


72

1208

03/12/2025 10:30:10

1344660387677724

XLON


273

1206

03/12/2025 10:31:58

1344660387677854

XLON


308

1204

03/12/2025 10:48:44

1344660387679533

XLON


26

1204

03/12/2025 10:48:44

1344660387679534

XLON


20

1204

03/12/2025 10:48:44

1344660387679535

XLON


158

1202

03/12/2025 10:48:44

1344660387679539

XLON


76

1202

03/12/2025 10:48:44

1344660387679540

XLON


214

1202

03/12/2025 11:00:35

1344660387680842

XLON


426

1200

03/12/2025 11:39:46

1344660387684067

XLON


17

1204

03/12/2025 11:41:04

1344660387684147

XLON


54

1204

03/12/2025 11:42:01

1344660387684189

XLON


94

1216

03/12/2025 11:58:33

1344660387685190

XLON


399

1216

03/12/2025 11:58:33

1344660387685191

XLON


489

1214

03/12/2025 11:58:49

1344660387685210

XLON


89

1218

03/12/2025 12:13:36

1344660387686479

XLON


340

1218

03/12/2025 12:13:36

1344660387686480

XLON


1

1218

03/12/2025 12:13:36

1344660387686481

XLON


361

1218

03/12/2025 12:36:05

1344660387688270

XLON


103

1218

03/12/2025 12:36:05

1344660387688271

XLON


446

1216

03/12/2025 12:37:03

1344660387688342

XLON


456

1220

03/12/2025 12:38:17

1344660387688437

XLON


467

1220

03/12/2025 12:38:26

1344660387688450

XLON


467

1220

03/12/2025 12:41:17

1344660387688612

XLON


477

1220

03/12/2025 13:16:20

1344660387691562

XLON


478

1220

03/12/2025 13:17:00

1344660387691614

XLON


478

1220

03/12/2025 13:17:45

1344660387691738

XLON


255

1220

03/12/2025 13:17:45

1344660387691744

XLON


164

1220

03/12/2025 13:18:21

1344660387691847

XLON


320

1220

03/12/2025 13:18:21

1344660387691848

XLON


485

1220

03/12/2025 13:18:47

1344660387691937

XLON


486

1220

03/12/2025 13:18:47

1344660387691940

XLON


298

1218

03/12/2025 13:18:53

1344660387691956

XLON


240

1220

03/12/2025 13:19:42

1344660387692008

XLON


404

1220

03/12/2025 13:37:39

1344660387693706

XLON


258

1220

03/12/2025 13:37:50

1344660387693715

XLON


484

1220

03/12/2025 13:37:50

1344660387693722

XLON


484

1220

03/12/2025 13:38:00

1344660387693755

XLON


488

1220

03/12/2025 13:38:00

1344660387693761

XLON


488

1220

03/12/2025 13:38:14

1344660387693772

XLON


217

1220

03/12/2025 13:38:18

1344660387693778

XLON


56

1220

03/12/2025 13:38:29

1344660387693791

XLON


515

1220

03/12/2025 13:41:16

1344660387694081

XLON


510

1220

03/12/2025 13:42:02

1344660387694259

XLON


556

1220

03/12/2025 13:42:17

1344660387694297

XLON


598

1218

03/12/2025 13:42:22

1344660387694342

XLON


66

1216

03/12/2025 13:44:42

1344660387694571

XLON


176

1216

03/12/2025 13:47:14

1344660387694786

XLON


275

1216

03/12/2025 13:48:31

1344660387694944

XLON


37

1216

03/12/2025 13:48:31

1344660387694945

XLON


101

1216

03/12/2025 13:49:20

1344660387694988

XLON


94

1210

03/12/2025 14:21:47

1344660387698858

XLON


146

1210

03/12/2025 14:25:23

1344660387699122

XLON


33

1212

03/12/2025 14:34:14

1344660387701096

XLON


444

1212

03/12/2025 14:34:14

1344660387701097

XLON


444

1210

03/12/2025 14:35:43

1344660387701365

XLON


456

1210

03/12/2025 14:35:43

1344660387701369

XLON


555

1210

03/12/2025 14:48:23

1344660387703702

XLON


288

1210

03/12/2025 14:49:56

1344660387703947

XLON


568

1202

03/12/2025 14:50:09

1344660387704008

XLON


85

1204

03/12/2025 15:15:13

1344660387707930

XLON


592

1204

03/12/2025 15:23:51

1344660387709540

XLON


598

1202

03/12/2025 15:26:22

1344660387709926

XLON


71

1202

03/12/2025 15:31:03

1344660387710640

XLON


1

1202

03/12/2025 15:31:03

1344660387710641

XLON


146

1202

03/12/2025 15:36:27

1344660387711887

XLON


132

1202

03/12/2025 15:36:46

1344660387711967

XLON


 

 

Contacts

CVS Group plc                                                                                                                                                 via Camarco

Richard Fairman, CEO

Robin Alfonso, CFO

Paul Higgs, Chief Veterinary Officer

Charlotte Page, Head of Investor Relations

 

Peel Hunt LLP (Nominated Adviser & Joint Broker)                                                                                  +44 (0)20 7418 8900

Christopher Golden / James Steel / Andrew Clark

 

Berenberg (Joint Broker)                                                                                                                             +44 (0)20 3207 7800

Toby Flaux / Michael Burke / Milo Bonser / Brooke Harris-Lowing

 

Camarco (Financial PR)                                                                                                                            cvsg@camarco.co.uk

Ginny Pulbrook                                                                                                                                                +44 (0)7961 315 138

Letaba Rimell

Tilly Butcher

 

About CVS Group plc (www.cvsukltd.co.uk)

 

CVS Group is an AIM-listed provider of veterinary services with operations in the UK and Australia.  CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

 

The Group now operates c.470 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business ("Animed Direct").

 

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

CVS Group (CVSG)
UK 100

Latest directors dealings